Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04113434 · ClinicalTrials.gov registry record
Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 513
- Enrollment target
NCT04113434: Completed study, sponsored by Children's Hospital of Philadelphia.
NCT04113434 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 513 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04113434 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 513 participants
- Enrollment target
Study Summary
The overall goal of the study is to risk stratify pediatric Acute Respiratory Distress Syndrome (ARDS) patients and to identify sub-phenotypes with shared biology in order to appropriately target therapies in future trials. This is a prospective, multicenter study of 500 intubated children with ARDS, with planned blood collection within 24 hours of ARDS onset and subsequent measurement of plasma protein biomarkers and peripheral blood gene expression.
Primary Outcome
28 day all cause mortality.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 513 participants |
| Start Date | 2020-01-07 |
| Est. Completion | 2025-04-01 |
What the finished NCT04113434 record still lists
NCT04113434 is an observational study that tracks outcomes without assigning an intervention. The registered 513 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04113434 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04113434 about?
NCT04113434 is a clinical study titled "Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome". The overall goal of the study is to risk stratify pediatric Acute Respiratory Distress Syndrome (ARDS) patients and to identify sub-phenotypes with shared biology in order to appropriately target therapies in future trials. This is a prospective, multicenter study of 500 intubated children with ARDS...
What is the current status of trial NCT04113434?
This trial is currently completed. The enrollment target is 513 participants. The study started on 2020-01-07. Estimated completion is 2025-04-01.
Who is sponsoring clinical trial NCT04113434?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
- NCT06585488 · 514 participants · Phase 1
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification
- NCT06716606 · 514 participants · Phase 3
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI